The seasonal timing of when infants receive the new respiratory syncytial virus (RSV) immunization is crucial for ensuring its effectiveness, according to Yale research published in ...
Systemic sclerosis, or scleroderma, causes the hardening of skin and connective tissues. Often, the disease harms other organs, such as the heart, kidneys, lungs, and gastrointestinal tract, and it can lead to death.
Understanding and categorizing the various types of tubulointerstitial responses in acute kidney injury (AKI) may lead to the development of new treatments for the condition, according to a new Yale School of Medicine study published in The Journal of Clinical Investigation on March 17.
Neutrophils, the most abundant immune cells in our bodies, are known for their destructive roles: killing pathogens, clearing out infections, and, sometimes to our detriment, wreaking havoc on surrounding tissues in the process.
After spending years tracing the origin and migration pattern of an unusual type of immune cell in mice, researchers have shown in a new study how activity of 鈥済ood鈥� microbes in the gut is linked to rheumatoid arthritis and, potentially, other autoimmune diseases.
Biotechnology researchers at Rensselaer Polytechnic Institute (RPI) are working to further improve mRNA therapeutics, with the aim of reducing manufacturing costs and enabling additional therapeutic uses for mRNA technology. 聽The team鈥檚 work will focus on improving mRNA manufacturing. Synthetizing mRNA vaccines involves a series of complex chemical reactions.
The Wistar Institute has recruited Xiaoyu (Ariel) Zhou, Ph.D., as assistant professor in the Vaccine & Immunotherapy Center.
A Ludwig Cancer Research study has identified a specific mode of fat uptake by immune cells within tumors that serves as a metabolic checkpoint against anti-cancer immune responses.
Today, Penn Medicine celebrated the groundbreaking of the Roberts Proton Therapy Center at Penn Presbyterian Medical Center in University City, which is expected to open for patient care in late 2027.
A new study from researchers at Moffitt Cancer Center shows that blocking a chemical process called nitrosylation could make one of the most aggressive forms of melanoma more treatable.
An international phase 3 clinical trial led by Washington University School of Medicine in St. Louis and Dana-Farber Brigham Cancer Center shows that patients with certain locally advanced head and neck cancers benefited from the addition of the immunotherapy drug pembrolizumab (brand name Keytruda) to standard-of-care therapy. Patients who received pembrolizumab saw greater tumor shrinkage prior to surgery and, on average, survived cancer-free almost two years longer than did patients who only received standard-of-care therapy.
Patients with advanced non-small cell lung cancer (NSCLC) are often treated with immunotherapy drugs known as checkpoint inhibitors, which are designed to strengthen the immune system鈥檚 ability to kill cancer cells 鈥� but these drugs do not produce a lasting response in most patients with this cancer type.
Ludwig Cancer Research released today the full scope of research to be presented by Ludwig-affiliated scientists at the American Association for Cancer Research (AACR) Annual Meeting 2025, which will be held online and in person in Chicago, from April 25 to April 30.
Wren Laboratories, a leader in molecular diagnostics, is proud to announce that its breakthrough liquid biopsy test, PROSTest鈩�, has been approved by the New York State Department of Health Clinical Laboratory Evaluation Program (NYSDOH-CLEP).
Indiana University School of Medicine scientists have developed a new imaging technique to study bone marrow in mouse models. This advancement could support future drug development and therapies for conditions involving bone marrow, including cancers, autoimmune diseases and musculoskeletal disorders.
Immunologist Shane Crotty, Ph.D., Professor and Chief Scientific Officer at La Jolla Institute for Immunology (LJI) has been elected to the American Academy of Arts and Sciences.
In his fourth year of study in the University of Northern Colorado鈥檚 (UNC) Sport and Exercise Science Ph.D. 鈥� Exercise Physiology Concentration program, Edwin Rodriguez is embarking on research for cancer patients.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal 蜜桃传媒 keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right